Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (12): 1352-1355.

Previous Articles     Next Articles

Improve and correct the Clinical Guide to Platelet Aggregation Inhibitors for no-cardiac surgery

YAN Fu-qin1, FAN Zhen2   

  1. 1General Hospital of Chinese People's Armed Police Forces, Beijing 100039, China;
    2Beijing Health Law Society, Beijing 100050, China
  • Received:2014-01-28 Revised:2014-11-17 Published:2020-07-20

Abstract: Platelet aggregation inhibitors therapy, such as aspirin or clopidegrel, should be stopped for 5-7 d before no-cardiac surgery in the Clinical Guide to the Chinese Pharmacopoeia 2010 and Chinese National Formulary for Children (CNFC). Platelet regenerating time in blood, being 7-14 d, is longer than the time stopping therapy for 5-7 d. It would be blood preoperative for no-cardiac surgery because of lots of platelets without coagulation function existing in blood. The precaution of aspirin and clopidegrel in the Clinical Guide to the Chinese Pharmacopoeia 2010 and Chinese National Formulary(CNF) should be improved. To prevent bleeding in selective operations, no administration of aspirin and clopidegrel should be set at 10-14 days before the operation. If bleeding in or after the operation, fresh platelet should be transfused to stop the bleeding. The precaution of ticlopidine in the Chinese National Formulary 2010 and Chinese National Formulary for Children is not correct because no administrating ticlopidine 10-24 d before the operation should be corrected as 10-14 days before the operation.

Key words: aspirin, clopidegrel, ticlopidine, platelet, CNF

CLC Number: